BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33218035)

  • 1.
    Schabort JJ; Nam AR; Lee KH; Kim SW; Lee JE; Cho JY
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer.
    Nam AR; Lee KH; Hwang HJ; Schabort JJ; An JH; Won SH; Cho JY
    Clin Epigenetics; 2020 Jul; 12(1):110. PubMed ID: 32693820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of LINE-1 in cell-free DNA serves as a liquid biopsy biomarker for human breast cancers and dog mammary tumors.
    Lee KH; Shin TJ; Kim WH; Cho JY
    Sci Rep; 2019 Jan; 9(1):175. PubMed ID: 30655558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
    Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
    Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular carcinogenesis of canine mammary tumors: news from an old disease.
    Klopfleisch R; von Euler H; Sarli G; Pinho SS; Gärtner F; Gruber AD
    Vet Pathol; 2011 Jan; 48(1):98-116. PubMed ID: 21149845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current biomarkers of canine mammary tumors.
    Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
    Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer.
    Jeong SJ; Lee KH; Nam AR; Cho JY
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
    BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.
    Harman RM; Curtis TM; Argyle DJ; Coonrod SA; Van de Walle GR
    J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):51-66. PubMed ID: 27002722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
    Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
    Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
    Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
    Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
    Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
    Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
    Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
    Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome Analyses Reveal Positive Association of COL2A1, MPO, TYMS, and IGFBP5 with Canine Mammary Gland Malignancy.
    Wu CC; Chang SC; Zeng GY; Chu HW; Huang Y; Liu HP
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800151. PubMed ID: 30578659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
    Park HM; Kim H; Kim DW; Yoon JH; Kim BG; Cho JY
    BMB Rep; 2020 Dec; 53(12):664-669. PubMed ID: 33298249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling canine mammary tumors: A potential model for studying human breast cancer.
    Gherman LM; Chiroi P; Nuţu A; Bica C; Berindan-Neagoe I
    Vet J; 2024 Feb; 303():106055. PubMed ID: 38097103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
    Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
    Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
    Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
    Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer.
    Inglebert M; Dettwiler M; Hahn K; Letko A; Drogemuller C; Doench J; Brown A; Memari Y; Davies HR; Degasperi A; Nik-Zainal S; Rottenberg S
    Sci Rep; 2022 Oct; 12(1):18051. PubMed ID: 36302863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
    van Garderen E; Schalken JA
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.